Specifically Targeting ERK1 or ERK2 Kills Melanoma Cells

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-10-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis

Cells
2019English

Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells From HIV-Infected Individuals

Frontiers in Medicine
Medicine
2016English

Water-Pipe Smoking Promotes Epithelial–mesenchymal Transition and Invasion of Human Breast Cancer Cells via ERK1/ERK2 Pathways

Cancer Cell International
Cancer ResearchOncologyGenetics
2018English

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

Targeting Metastatic Melanoma

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

Pharmacological Targeting of Valosin Containing Protein (VCP) Induces DNA Damage and Selectively Kills Canine Lymphoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Carbon-Ion Beam Irradiation Alone or in Combination With Zoledronic Acid Effectively Kills Osteosarcoma Cells

Cancers
Cancer ResearchOncology
2020English

Human CD4+ T Cells Specifically Recognize a Shared Melanoma-Associated Antigen Encoded by the Tyrosinase Gene.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

TPL2-mediated Activation of ERK1 and ERK2 Regulates the Processing of Pre-TNF in LPS-stimulated Macrophages

Journal of Cell Science
Cell Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy